Cansortium Future Growth

Future criteria checks 0/6

Cansortium's EPS is expected to grow by 137.5% per annum.

Key information

n/a

Earnings growth rate

137.5%

EPS growth rate

Pharmaceuticals earnings growth54.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Cansortium (CSE:TIUM.U) Seems To Be Using A Lot Of Debt

Oct 25
Cansortium (CSE:TIUM.U) Seems To Be Using A Lot Of Debt

Cansortium Inc. (CSE:TIUM.U) Soars 30% But It's A Story Of Risk Vs Reward

Sep 04
Cansortium Inc. (CSE:TIUM.U) Soars 30% But It's A Story Of Risk Vs Reward

Cansortium Inc.'s (CSE:TIUM.U) CEO Compensation Is Looking A Bit Stretched At The Moment

Aug 21
Cansortium Inc.'s (CSE:TIUM.U) CEO Compensation Is Looking A Bit Stretched At The Moment

Slammed 32% Cansortium Inc. (CSE:TIUM.U) Screens Well Here But There Might Be A Catch

Jul 11
Slammed 32% Cansortium Inc. (CSE:TIUM.U) Screens Well Here But There Might Be A Catch

Cansortium Inc.'s (CSE:TIUM.U) Shares Not Telling The Full Story

Jan 15
Cansortium Inc.'s (CSE:TIUM.U) Shares Not Telling The Full Story

Is Cansortium (CSE:TIUM.U) Using Too Much Debt?

Nov 30
Is Cansortium (CSE:TIUM.U) Using Too Much Debt?

Is Cansortium (CSE:TIUM.U) Using Debt Sensibly?

Sep 01
Is Cansortium (CSE:TIUM.U) Using Debt Sensibly?

Cansortium Inc. (CSE:TIUM.U) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

Jul 28
Cansortium Inc. (CSE:TIUM.U) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

An Intrinsic Calculation For Cansortium Inc. (CSE:TIUM.U) Suggests It's 26% Undervalued

Mar 08
An Intrinsic Calculation For Cansortium Inc. (CSE:TIUM.U) Suggests It's 26% Undervalued

Does Cansortium (CSE:TIUM.U) Have A Healthy Balance Sheet?

Jan 09
Does Cansortium (CSE:TIUM.U) Have A Healthy Balance Sheet?

Here's Why Cansortium (CSE:TIUM.U) Has A Meaningful Debt Burden

Sep 09
Here's Why Cansortium (CSE:TIUM.U) Has A Meaningful Debt Burden

Earnings and Revenue Growth Forecasts

CNSX:TIUM.U - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2024103-13815N/A
3/31/2024100-201117N/A
12/31/202397-231218N/A
9/30/202395-361521N/A
6/30/202392-361219N/A
3/31/202390-341320N/A
12/31/202288-371219N/A
9/30/202283-152234N/A
6/30/202276-2724N/A
3/31/202270-24-210N/A
12/31/202165-19-26-5N/A
9/30/202162-31-38-20N/A
6/30/202161-47-26-15N/A
3/31/202157-28-15N/A
12/31/202052-3717N/A
9/30/202047-481217N/A
6/30/202040-51-52N/A
3/31/202033-51-21-8N/A
12/31/201929-53-37-23N/A
9/30/201924-54-58-42N/A
6/30/201919-13-46-29N/A
3/31/201914-9-35-23N/A
12/31/201880-22-12N/A
9/30/2018316-16-7N/A
6/30/20180-15-13-8N/A
3/31/20180-16N/A-7N/A
12/31/2017N/A-10N/A-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if TIUM.U's forecast earnings growth is above the savings rate (2.2%).

Earnings vs Market: Insufficient data to determine if TIUM.U's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if TIUM.U's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if TIUM.U's revenue is forecast to grow faster than the Canadian market.

High Growth Revenue: Insufficient data to determine if TIUM.U's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TIUM.U's Return on Equity is forecast to be high in 3 years time


Discover growth companies